The FDA has issued an emergency use authorization (EUA) that would allow the use of the Centers for Disease Control and Prevention’s (CDC) 2019-nCoV Real-Time RT-PCR Diagnostic Panel by any CDC-qualified lab across the US.
Reference prices are associated with lower prices paid by employers and lower cost sharing by employees.
Having many patients with multiple chronic diseases may raise the mental strain of general practitioners.
Online direct-to-consumer pharmaceutical companies can give rise to distinct ethical challenges including potential conflicts of interest for prescribing physicians.
Large proportions of antibiotic prescriptions for Medicaid patients are filled without evidence of infection-related diagnoses or clinician visits.
Using negotiated prices and a defined formulary, similar to the Department of Veterans Affairs (VA), Medicare could save billions of dollars on prescription insulin for patients with diabetes, according to a research letter published online Feb. 3 in JAMA Internal Medicine.
Prescription drug monitoring program data from individual states show a decline in opioid prescribing rates in 11 participating states from 2010 to 2016.
Most measures of unmet need for physician services in the United States have not improved since 1998 despite gains in health insurance coverage.
As of February 3, 2020, there are 11 confirmed cases of 2019 novel coronavirus (2019-nCov) in the US, according to the Centers for Disease Control and Prevention.
A small proportion of providers account for almost half of all opioid doses and about one-quarter of opioid prescriptions.